%PDF-1.4
%
80 0 obj
<>
endobj
76 0 obj
<>
endobj
150 0 obj
<>stream
Acrobat Distiller 5.0 for Macintosh
2002-12-09T22:59:44Z
2024-03-29T05:40:09-07:00
2024-03-29T05:40:09-07:00
QuarkXPress. 4.11: AdobePS 8.7.2 (104)
application/pdf
Heather
2001-300.jan
uuid:11fa2f0e-1dd2-11b2-0a00-270927bd7700
uuid:11fa2f11-1dd2-11b2-0a00-900000000000
endstream
endobj
65 0 obj
<>
endobj
66 0 obj
<>
endobj
81 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
18 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
26 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
39 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
52 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
184 0 obj
[188 0 R]
endobj
185 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 7.76 0 0 8 72 714.5293 Tm
(specific immune response to )Tj
/T1_1 1 Tf
[-0.4 (Chlamydia trachomatis)]TJ
/T1_0 1 Tf
21.4779 0 Td
[(in Reiter)-37 (\325)55.1 (s)]TJ
-21.4779 -1.25 Td
[(disease. )54.8 (Arthritis Rheum 1991;34:588-98.)]TJ
-1.8943 -1.25 Td
[(29.)-644.4 (Laitio P)110.7 (,)-0.1 ( )17.7 (V)59.8 (irtala M, Salmi M, Pelliniemi LJ, )36.8 (Y)110.8 (u DTY)128.8 (, Granfors K.)]TJ
1.8943 -1.25 Td
(HLA-B27 modulates intracellular survival of )Tj
/T1_1 1 Tf
[-0.3 (Salmonella enteritidis)]TJ
/T1_0 1 Tf
-0.0002 Tc 0 Tw 27.5276 0 Td
(in)Tj
-0.00011 Tc 0.02499 Tw -27.5276 -1.25 Td
(human monocytic cells. Eur J Immunol 1997;27:1331-8.)Tj
-1.8943 -1.25 Td
[(30.)-644.4 (Sambrook J, Fritsch EF)79.7 (, Maniatis )17.7 (T)74 (. Molecular cloning: )54.8 (A)-220.1 (laboratory)]TJ
1.8943 -1.25 Td
[(manual. 2nd ed. Cold Spring Harbor)39.7 (, NY)91.7 (: Cold Spring Harbor)]TJ
0 -1.25 TD
(Laboratory Press; 1989:9.16-9.19.)Tj
-1.8943 -1.25 Td
[(31.)-644.4 (T)69.9 (onks S, Marsh SGE, Bunce M, Bodmer JG. Molecular typing for)]TJ
1.8943 -1.25 Td
[(HLA)-220.2 (class I using )54.8 (ARMS-PCR: Further development following the)]TJ
T*
[(12th international histocompatibility workshop. )17.7 (T)35 (issue )54.8 (Antigens)]TJ
0 Tc 0 Tw T*
(1999;53:175-83.)Tj
-0.00011 Tc 0.02499 Tw -1.8943 -1.25 Td
[(32.)-644.4 (Sieper J, Braun J, Brandt J, et al. Pathogenetic role of )]TJ
/T1_1 1 Tf
0 Tw 23.8007 0 Td
(Chlamydia)Tj
/T1_0 1 Tf
0 Tc [-0.4 (,)]TJ
/T1_1 1 Tf
-21.9064 -1.25 Td
(Y)Tj
-0.00011 Tc 0.4641 0 Td
(ersinia)Tj
/T1_0 1 Tf
0 Tc 3.0523 0 Td
(and )Tj
/T1_1 1 Tf
-0.00011 Tc 1.7189 0 Td
[(Borr)36.8 (elia)]TJ
/T1_0 1 Tf
0.02499 Tw 3.6263 0 Td
[(in undif)17.7 (ferentiated oligoarthritis. J Rheumatol)]TJ
0 Tc 0 Tw -8.8616 -1.25 Td
(1992;19:1236-42.)Tj
-0.00011 Tc 0.02499 Tw -1.8943 -1.25 Td
[(33.)-644.4 (Gaston JS, Life PF)79.7 (, Granfors K, et al. Synovial )17.7 (T)-257.1 (lymphocyte)]TJ
1.8943 -1.25 Td
[(recognition of or)17.7 (ganisms that trigger reactive arthritis. Clin Exp)]TJ
T*
(Immunol 1989;76:348-53.)Tj
-1.8943 -1.25 Td
[(34.)-644.4 (Kim JH, Krenn )17.7 (V)128.9 (, Steinhauser G, Berek C. Plasma cell development)]TJ
1.8943 -1.25 Td
(in synovial germinal centers in patients with rheumatoid and reactive)Tj
T*
(arthritis. J Immunol 1999;162:3053-62.)Tj
-1.8943 -1.25 Td
[(35.)-644.4 (Berek C, Kim JH. B-cell activation and development within)]TJ
1.8943 -1.25 Td
(chronically inflamed synovium in rheumatoid and reactive arthritis.)Tj
T*
(Semin Immunol 1997;9:261-8.)Tj
32.1263 28.75 Td
[(36.)-644.4 (Sieper J, Braun J, )17.7 (W)39.8 (u)-0.1 ( P)110.7 (, Kingsley GH. )17.7 (T)-257.1 (cells are responsible for the)]TJ
1.8943 -1.25 Td
(enhanced synovial cellular immune response to triggering antigen in)Tj
T*
(reactive arthritis. Clin Exp Immunol 1993;91:96-102.)Tj
-1.8943 -1.25 Td
[(37.)-644.4 (Sieper J, Braun J, Kingsley GH. Reports on the 4th International)]TJ
0 Tc 0 Tw 1.8943 -1.25 Td
(W)Tj
-0.00011 Tc 0.02499 Tw 0.864 0 Td
[(orkshop on Reactive )54.8 (Arthritis. )54.8 (Arthritis Rheum 2000;43:720-34.)]TJ
-2.7584 -1.25 Td
[(38.)-644.4 (Simon )54.8 (AK, Seipelt E, )17.7 (W)39.8 (u)-0.1 ( P)110.7 (,)-0.1 ( )17.7 (W)79.9 (enzel B, Braun J, Sieper J. )54.8 (Analysis of)]TJ
1.8943 -1.25 Td
[(cytokine profiles in synovial )17.7 (T)-257.1 (cell clones from )]TJ
/T1_1 1 Tf
0 Tw 19.38 0 Td
(Chlamydia)Tj
/T1_0 1 Tf
-0.0002 Tc 4.6634 0 Td
(reactive)Tj
-0.00011 Tc 0.02499 Tw -24.0434 -1.25 Td
[(arthritis patients: predominance of the )17.7 (Th1 subset. Clin Exp Immunol)]TJ
0 Tc 0 Tw T*
(1993;94:122-6.)Tj
-0.00011 Tc 0.02499 Tw -1.8943 -1.25 Td
[(39.)-644.4 (Schlaak J, Hermann E, Ringhof)17.7 (fer M, et al. Predominance of )17.7 (Th1-type)]TJ
0 Tc 0 Tw 1.8943 -1.25 Td
(T)Tj
-0.00011 Tc 0.02499 Tw 0.868 0 Td
(cells in synovial fluid of patients with )Tj
/T1_1 1 Tf
0 Tc 0 Tw 15.5324 0 Td
(Y)Tj
-0.00011 Tc 0.4641 0 Td
(ersinia)Tj
/T1_0 1 Tf
0.02499 Tw (-induced reactive)Tj
-16.8646 -1.25 Td
(arthritis. Eur J Immunol 1992;22:2771-6.)Tj
-1.8943 -1.25 Td
[(40.)-644.4 (Bachmann MF)79.7 (, Ohashi PS. )17.7 (The role of )17.7 (T)91.8 (-cell receptor dimerization in)]TJ
0 Tc 0 Tw 1.8943 -1.25 Td
(T)Tj
-0.00011 Tc 0.02499 Tw 0.519 0 Td
[(-cell activation. Immunol )17.7 (T)69.9 (oday 1999;20:568-75.)]TJ
-2.4134 -1.25 Td
[(41.)-644.4 (Sloan-Lancaster J, )54.8 (Allen PM. )54.8 (Altered peptide ligand-induced partial )17.7 (T)]TJ
1.8943 -1.25 Td
[(cell activation: molecular mechanisms and role in )17.7 (T)-257.1 (cell biology)64.8 (. )54.8 (Annu)]TJ
T*
(Rev Immunol 1996;14:1-27.)Tj
-1.8943 -1.25 Td
[(42.)-644.4 (Paul )17.7 (WE, Seder RA. L)54.8 (ymphocyte responses and cytokines. Cell)]TJ
0 Tc 0 Tw 1.8943 -1.25 Td
(1994;76:241-51.)Tj
-0.00011 Tc 0.02499 Tw -1.8943 -1.25 Td
[(43.)-644.4 (Cohen S. Cytokine profile data. Immunol )17.7 (T)69.9 (oday 2000;21:199-200.)]TJ
T*
[(44.)-644.4 (Abbas )54.8 (AK, Murphy KM, Sher )54.8 (A. Functional diversity of helper )17.7 (T)]TJ
1.8943 -1.25 Td
(lymphocytes. Nature 1996;383:787-93.)Tj
-1.8943 -1.25 Td
[(45.)-644.4 (Del Prete G, De Carli M, D\325Elios MM, et al. CD30-mediated)]TJ
1.8943 -1.25 Td
[(signalling promotes the development of human )17.7 (T)-257.1 (helper type 2-like )17.7 (T)]TJ
T*
(cells. J Exp Med 1995;182:1655-61.)Tj
ET
0 0 0 0 scn
438 770 120 -25 re
f
BT
0 0 0 1 scn
/T1_2 1 Tf
0 Tw 20.37 0 0 21 439 753.6089 Tm
(2001-300-9)Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 54.5 35.9844 Tm
[(Sinha, et al: Salmonella in ReA)-257.3 (and SpA)]TJ
0 Tc 0 Tw 61.4375 -0.0313 Td
(113)Tj
ET
0 0 0 0 scn
/GS0 gs
110.22 59.09 396.48 -10.84 re
f
0.5 w
110.22 59.09 396.48 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
87 0 obj
<>
endobj
83 0 obj
<>
endobj
85 0 obj
<>
endobj
131 0 obj
<>
endobj
155 0 obj
<>
endobj
91 0 obj
<>
endobj
89 0 obj
<>
endobj
88 0 obj
<>stream
HTKo0|
; qi5=viF=ώYWlApw64^A8w`{3/7(pfiAnzPobVo͐Bۂ.Q_8O;